{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T04:02:27Z","timestamp":1747454547820,"version":"3.40.5"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005242","name":"Universit\u00e9 de Montr\u00e9al","doi-asserted-by":"publisher","award":["Universit\u00e9 de Montr\u00e9al"],"award-info":[{"award-number":["Universit\u00e9 de Montr\u00e9al"]}],"id":[{"id":"10.13039\/501100005242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000263","name":"Parkinson Society Canada","doi-asserted-by":"publisher","award":["2018\u201000,355"],"award-info":[{"award-number":["2018\u201000,355"]}],"id":[{"id":"10.13039\/501100000263","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IUGM Foundation","award":["IUGM Foundation"],"award-info":[{"award-number":["IUGM Foundation"]}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","award":["Fonds de Recherche du Qu\u00e9bec - Sant\u00e9"],"award-info":[{"award-number":["Fonds de Recherche du Qu\u00e9bec - Sant\u00e9"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lemaire Foundation","award":["Lemaire Foundation"],"award-info":[{"award-number":["Lemaire Foundation"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10072-025-08045-6","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T07:38:25Z","timestamp":1739950705000},"page":"2611-2625","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Classification of Parkinson\u2019s disease with and without dopaminergic deficiency based on non-motor symptoms and structural neuroimaging"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1943-9833","authenticated-orcid":false,"given":"Lucas","family":"Ronat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Rainville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oury","family":"Monchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandru","family":"Hanganu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"8045_CR1","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"key":"8045_CR2","doi-asserted-by":"publisher","first-page":"1213393","DOI":"10.1155\/2022\/1213393","volume":"2022","author":"P Mac\u00edas-Garc\u00eda","year":"2022","unstructured":"Mac\u00edas-Garc\u00eda P, Rashid-L\u00f3pez R, Cruz-G\u00f3mez \u00c1J et al (2022) Neuropsychiatric symptoms in clinically defined Parkinson\u2019s Disease: an updated review of literature. Behav Neurol 2022:1213393. https:\/\/doi.org\/10.1155\/2022\/1213393","journal-title":"Behav Neurol"},{"key":"8045_CR3","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3233\/JPD-150604","volume":"5","author":"D Aarsland","year":"2015","unstructured":"Aarsland D, Kramberger MG (2015) Neuropsychiatric symptoms in Parkinson\u2019s Disease. J Park Dis 5:659\u2013667. https:\/\/doi.org\/10.3233\/JPD-150604","journal-title":"J Park Dis"},{"key":"8045_CR4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18:435\u2013450. https:\/\/doi.org\/10.1038\/nrn.2017.62","journal-title":"Nat Rev Neurosci"},{"key":"8045_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s12264-013-1390-3","volume":"30","author":"Q Xiao","year":"2014","unstructured":"Xiao Q, Chen S, Le W (2014) Hyposmia: a possible biomarker of Parkinson\u2019s disease. Neurosci Bull 30:134\u2013140. https:\/\/doi.org\/10.1007\/s12264-013-1390-3","journal-title":"Neurosci Bull"},{"key":"8045_CR6","doi-asserted-by":"publisher","first-page":"101759","DOI":"10.1016\/j.smrv.2023.101759","volume":"68","author":"G Maggi","year":"2023","unstructured":"Maggi G, Vitale C, Cerciello F, Santangelo G (2023) Sleep and wakefulness disturbances in Parkinson\u2019s disease: a meta-analysis on prevalence and clinical aspects of REM sleep behavior disorder, excessive daytime sleepiness and insomnia. Sleep Med Rev 68:101759. https:\/\/doi.org\/10.1016\/j.smrv.2023.101759","journal-title":"Sleep Med Rev"},{"key":"8045_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11910-018-0907-6","volume":"18","author":"A Hanganu","year":"2018","unstructured":"Hanganu A, Monchi O (2018) Interaction between neuropsychiatric symptoms and cognitive performance in Parkinson\u2019s Disease: what do clinical and Neuroimaging studies tell us? Curr Neurol Neurosci Rep 18:91. https:\/\/doi.org\/10.1007\/s11910-018-0907-6","journal-title":"Curr Neurol Neurosci Rep"},{"key":"8045_CR8","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00415-010-5465-z","volume":"257","author":"O Riedel","year":"2010","unstructured":"Riedel O, Klotsche J, Spottke A et al (2010) Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson\u2019s disease. J Neurol 257:1073\u20131082. https:\/\/doi.org\/10.1007\/s00415-010-5465-z","journal-title":"J Neurol"},{"key":"8045_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AH (2006) Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol 5:235\u2013245. https:\/\/doi.org\/10.1016\/S1474-4422(06)70373-8","journal-title":"Lancet Neurol"},{"key":"8045_CR10","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S1474-4422(21)00330-6","volume":"21","author":"D Weintraub","year":"2022","unstructured":"Weintraub D, Aarsland D, Chaudhuri KR et al (2022) The neuropsychiatry of Parkinson\u2019s disease: advances and challenges. Lancet Neurol 21:89\u2013102. https:\/\/doi.org\/10.1016\/S1474-4422(21)00330-6","journal-title":"Lancet Neurol"},{"key":"8045_CR11","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.nrleng.2014.10.016","volume":"31","author":"K Berganzo","year":"2016","unstructured":"Berganzo K, Tijero B, Gonz\u00e1lez-Eizaguirre A et al (2016) Motor and non-motor symptoms of Parkinson\u2019s disease and their impact on quality of life and on different clinical subgroups. Neurol Engl Ed 31:585\u2013591. https:\/\/doi.org\/10.1016\/j.nrleng.2014.10.016","journal-title":"Neurol Engl Ed"},{"key":"8045_CR12","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s40520-020-01470-x","volume":"32","author":"M De Rui","year":"2020","unstructured":"De Rui M, Inelmen EM, Trevisan C et al (2020) Parkinson\u2019s disease and the non-motor symptoms: hyposmia, weight loss, osteosarcopenia. Aging Clin Exp Res 32:1211\u20131218. https:\/\/doi.org\/10.1007\/s40520-020-01470-x","journal-title":"Aging Clin Exp Res"},{"key":"8045_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3233\/JPD-130301","volume":"4","author":"W Schrempf","year":"2014","unstructured":"Schrempf W, Brandt MD, Storch A, Reichmann H (2014) Sleep disorders in Parkinson\u2019s Disease. J Park Dis 4:211\u2013221. https:\/\/doi.org\/10.3233\/JPD-130301","journal-title":"J Park Dis"},{"key":"8045_CR14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2174\/1567205018666210827122133","volume":"18","author":"R Bishnoi","year":"2021","unstructured":"Bishnoi R, Badir MC, Surya S, Youssef NA (2021) Predicting neuropsychiatric symptoms of Parkinson\u2019s Disease with measures of Striatal Dopaminergic Deficiency. Curr Alzheimer Res 18:499\u2013504. https:\/\/doi.org\/10.2174\/1567205018666210827122133","journal-title":"Curr Alzheimer Res"},{"key":"8045_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.parkreldis.2017.02.010","volume":"37","author":"M Picillo","year":"2017","unstructured":"Picillo M, Santangelo G, Erro R et al (2017) Association between dopaminergic dysfunction and anxiety in de novo Parkinson\u2019s disease. Parkinsonism Relat Disord 37:106\u2013110. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.02.010","journal-title":"Parkinsonism Relat Disord"},{"key":"8045_CR16","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s00702-015-1405-5","volume":"122","author":"KA Jellinger","year":"2015","unstructured":"Jellinger KA (2015) Neuropathobiology of non-motor symptoms in Parkinson disease. J Neural Transm 122:1429\u20131440. https:\/\/doi.org\/10.1007\/s00702-015-1405-5","journal-title":"J Neural Transm"},{"key":"8045_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jns.2011.04.012","volume":"310","author":"KA Jellinger","year":"2011","unstructured":"Jellinger KA (2011) Synuclein deposition and non-motor symptoms in Parkinson disease. J Neurol Sci 310:107\u2013111. https:\/\/doi.org\/10.1016\/j.jns.2011.04.012","journal-title":"J Neurol Sci"},{"key":"8045_CR18","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.jns.2015.06.037","volume":"356","author":"H Alzahrani","year":"2015","unstructured":"Alzahrani H, Venneri A (2015) Cognitive and neuroanatomical correlates of neuropsychiatric symptoms in Parkinson\u2019s disease: a systematic review. J Neurol Sci 356:32\u201344. https:\/\/doi.org\/10.1016\/j.jns.2015.06.037","journal-title":"J Neurol Sci"},{"key":"8045_CR19","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1212\/01.WNL.0000149510.41793.50","volume":"64","author":"A Nagano-Saito","year":"2005","unstructured":"Nagano-Saito A, Washimi Y, Arahata Y et al (2005) Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 64:224\u2013229. https:\/\/doi.org\/10.1212\/01.WNL.0000149510.41793.50","journal-title":"Neurology"},{"key":"8045_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/cns.13188","volume":"26","author":"C Zhou","year":"2020","unstructured":"Zhou C, Guan X-J, Guo T et al (2020) Progressive brain atrophy in Parkinson\u2019s disease patients who convert to mild cognitive impairment. CNS Neurosci Ther 26:117\u2013125. https:\/\/doi.org\/10.1111\/cns.13188","journal-title":"CNS Neurosci Ther"},{"key":"8045_CR21","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 20:385\u2013397. https:\/\/doi.org\/10.1016\/S1474-4422(21)00030-2","journal-title":"Lancet Neurol"},{"key":"8045_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/jnnp-2014-310256","volume":"87","author":"R Erro","year":"2016","unstructured":"Erro R, Schneider SA, Stamelou M et al (2016) What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies. J Neurol Neurosurg Psychiatry 87:319\u2013323. https:\/\/doi.org\/10.1136\/jnnp-2014-310256","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8045_CR23","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/mds.26204","volume":"30","author":"FS Sprenger","year":"2015","unstructured":"Sprenger FS, Seppi K, Djamshidian A et al (2015) Nonmotor symptoms in subjects without evidence of dopaminergic deficits. Mov Disord off J Mov Disord Soc 30:976\u2013981. https:\/\/doi.org\/10.1002\/mds.26204","journal-title":"Mov Disord off J Mov Disord Soc"},{"key":"8045_CR24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/WNN.0000000000000107","volume":"29","author":"KA Wyman-Chick","year":"2016","unstructured":"Wyman-Chick KA, Martin PK, Min\u00e1r M, Schroeder RW (2016) Cognition in patients with a clinical diagnosis of Parkinson Disease and scans without evidence of dopaminergic deficit (SWEDD): 2-Year Follow-Up. Cogn Behav Neurol 29:190\u2013196. https:\/\/doi.org\/10.1097\/WNN.0000000000000107","journal-title":"Cogn Behav Neurol"},{"key":"8045_CR25","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.parkreldis.2014.09.024","volume":"20","author":"H-J Yang","year":"2014","unstructured":"Yang H-J, Kim YE, Yun JY et al (2014) Comparison of sleep and other non-motor symptoms between SWEDDs patients and de novo Parkinson\u2019s disease patients. Parkinsonism Relat Disord 20:1419\u20131422. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.09.024","journal-title":"Parkinsonism Relat Disord"},{"key":"8045_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jns.2017.11.039","volume":"385","author":"N Nicastro","year":"2018","unstructured":"Nicastro N, Burkhard PR, Garibotto V (2018) Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: a prospective study. J Neurol Sci 385:17\u201321. https:\/\/doi.org\/10.1016\/j.jns.2017.11.039","journal-title":"J Neurol Sci"},{"key":"8045_CR27","doi-asserted-by":"crossref","unstructured":"Pereira HR, Ferreira HA (2020) Classification of Patients with Parkinson\u2019s Disease Using Medical Imaging and Artificial Intelligence Algorithms. In: Henriques J, Neves N, de Carvalho P (eds) XV Mediterranean Conference on Medical and Biological Engineering and Computing \u2013 MEDICON 2019. Springer International Publishing, Cham, pp 2043\u20132056","DOI":"10.1007\/978-3-030-31635-8_241"},{"key":"8045_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1288\/00005537-198402000-00004","volume":"94","author":"RL Doty","year":"1984","unstructured":"Doty RL, Shaman P, Kimmelman CP, Dann MS (1984) University of pennsylvania smell identification test: a rapid quantitative olfactory function test for the clinic. Laryngoscope 94:176\u2013178. https:\/\/doi.org\/10.1288\/00005537-198402000-00004","journal-title":"Laryngoscope"},{"key":"8045_CR29","first-page":"153","volume":"0","author":"S FAHN","year":"1987","unstructured":"FAHN S (1987) Unified Parkinson\u2019s disease rating scale. Recent Dev Park Dis 0:153\u2013163","journal-title":"Recent Dev Park Dis"},{"key":"8045_CR30","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","volume":"17","author":"JA Yesavage","year":"1982","unstructured":"Yesavage JA, Brink TL, Rose TL et al (1982) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17:37\u201349. https:\/\/doi.org\/10.1016\/0022-3956(82)90033-4","journal-title":"J Psychiatr Res"},{"key":"8045_CR31","doi-asserted-by":"publisher","DOI":"10.30849\/rip\/ijp.v5i3","author":"CD Spielberger","year":"1971","unstructured":"Spielberger CD, Gonzalez-Reigosa F, Martinez-Urrutia A et al (1971) The state-trait anxiety inventory. Rev Interam Psicol J Psychol. https:\/\/doi.org\/10.30849\/rip\/ijp.v5i3","journal-title":"Rev Interam Psicol J Psychol"},{"key":"8045_CR32","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1378\/chest.103.1.30","volume":"103","author":"MW Johns","year":"1993","unstructured":"Johns MW (1993) Daytime sleepiness, snoring, and obstructive sleep apnea: the Epworth Sleepiness Scale. Chest 103:30\u201336. https:\/\/doi.org\/10.1378\/chest.103.1.30","journal-title":"Chest"},{"key":"8045_CR33","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/mds.25438","volume":"28","author":"LM Chahine","year":"2013","unstructured":"Chahine LM, Daley J, Horn S et al (2013) Questionnaire-based diagnosis of REM sleep behavior disorder in Parkinson\u2019s disease. Mov Disord 28:1146\u20131149. https:\/\/doi.org\/10.1002\/mds.25438","journal-title":"Mov Disord"},{"key":"8045_CR34","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/mds.22571","volume":"24","author":"D Weintraub","year":"2009","unstructured":"Weintraub D, Hoops S, Shea JA et al (2009) Validation of the questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease. Mov Disord off J Mov Disord Soc 24:1461\u20131467. https:\/\/doi.org\/10.1002\/mds.22571","journal-title":"Mov Disord off J Mov Disord Soc"},{"key":"8045_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/mds.23939","volume":"27","author":"DA Gallagher","year":"2012","unstructured":"Gallagher DA, Goetz CG, Stebbins G et al (2012) Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson\u2019s disease. Mov Disord 27:79\u201383. https:\/\/doi.org\/10.1002\/mds.23939","journal-title":"Mov Disord"},{"key":"8045_CR36","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V et al (2005) The Montreal Cognitive Assessment, MoCA: a brief Screening Tool for mild cognitive impairment. J Am Geriatr Soc 53:695\u2013699. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x","journal-title":"J Am Geriatr Soc"},{"key":"8045_CR37","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan RS, S\u00e9gonne F, Fischl B et al (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. NeuroImage 31:968\u2013980. https:\/\/doi.org\/10.1016\/j.neuroimage.2006.01.021","journal-title":"NeuroImage"},{"key":"8045_CR38","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0896-6273(02)00569-X","volume":"33","author":"B Fischl","year":"2002","unstructured":"Fischl B, Salat DH, Busa E et al (2002) Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 33:341\u2013355. https:\/\/doi.org\/10.1016\/S0896-6273(02)00569-X","journal-title":"Neuron"},{"key":"8045_CR39","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.1093\/brain\/awv283","volume":"138","author":"CR Jack","year":"2015","unstructured":"Jack CR, Wiste HJ, Weigand SD et al (2015) Different definitions of neurodegeneration produce similar amyloid\/neurodegeneration biomarker group findings. Brain J Neurol 138:3747\u20133759. https:\/\/doi.org\/10.1093\/brain\/awv283","journal-title":"Brain J Neurol"},{"key":"8045_CR40","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.bandc.2016.11.001","volume":"111","author":"A Hanganu","year":"2017","unstructured":"Hanganu A, Bruneau M-A, Degroot C et al (2017) Depressive symptoms in Parkinson\u2019s disease correlate with cortical atrophy over time. Brain Cogn 111:127\u2013133. https:\/\/doi.org\/10.1016\/j.bandc.2016.11.001","journal-title":"Brain Cogn"},{"key":"8045_CR41","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.parkreldis.2014.04.027","volume":"20","author":"C O\u2019Callaghan","year":"2014","unstructured":"O\u2019Callaghan C, Shine JM, Lewis SJG, Hornberger M (2014) Neuropsychiatric symptoms in Parkinson\u2019s disease: Fronto-striatal atrophy contributions. Parkinsonism Relat Disord 20:867\u2013872. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.04.027","journal-title":"Parkinsonism Relat Disord"},{"key":"8045_CR42","doi-asserted-by":"publisher","first-page":"e6074","DOI":"10.1002\/gps.6074","volume":"39","author":"N Rashidi-Ranjbar","year":"2024","unstructured":"Rashidi-Ranjbar N, Churchill NW, Black SE et al (2024) Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: a cross sectional and longitudinal study. Int J Geriatr Psychiatry 39:e6074. https:\/\/doi.org\/10.1002\/gps.6074","journal-title":"Int J Geriatr Psychiatry"},{"key":"8045_CR43","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1474-4422(04)00740-9","volume":"3","author":"AE Lang","year":"2004","unstructured":"Lang AE, Obeso JA (2004) Challenges in Parkinson\u2019s disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol 3:309\u2013316. https:\/\/doi.org\/10.1016\/S1474-4422(04)00740-9","journal-title":"Lancet Neurol"},{"key":"8045_CR44","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1749-6632.2000.tb06900.x","volume":"920","author":"MG Spillantini","year":"2000","unstructured":"Spillantini MG, Goedert M (2000) The \u03b1-Synucleinopathies: Parkinson\u2019s Disease, Dementia with Lewy Bodies, and multiple system atrophy. Ann N Y Acad Sci 920:16\u201327. https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb06900.x","journal-title":"Ann N Y Acad Sci"},{"key":"8045_CR45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrneurol.2011.189","volume":"8","author":"D Aarsland","year":"2012","unstructured":"Aarsland D, P\u00e5hlhagen S, Ballard CG et al (2012) Depression in Parkinson disease\u2014epidemiology, mechanisms and management. Nat Rev Neurol 8:35\u201347. https:\/\/doi.org\/10.1038\/nrneurol.2011.189","journal-title":"Nat Rev Neurol"},{"key":"8045_CR46","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S1353-8020(09)70769-2","volume":"15","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Fujishiro H, Orr C et al (2009) Neuropathology of non-motor features of Parkinson disease. Parkinsonism Relat Disord 15:S1\u2013S5. https:\/\/doi.org\/10.1016\/S1353-8020(09)70769-2","journal-title":"Parkinsonism Relat Disord"},{"key":"8045_CR47","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.neuint.2016.11.009","volume":"102","author":"Y Vermeiren","year":"2017","unstructured":"Vermeiren Y, De Deyn PP (2017) Targeting the norepinephrinergic system in Parkinson\u2019s disease and related disorders: the locus coeruleus story. Neurochem Int 102:22\u201332. https:\/\/doi.org\/10.1016\/j.neuint.2016.11.009","journal-title":"Neurochem Int"},{"key":"8045_CR48","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1176\/appi.ajp.2014.13060821","volume":"171","author":"YE Geda","year":"2014","unstructured":"Geda YE, Roberts RO, Mielke MM et al (2014) Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: a Population-based study. Am J Psychiatry 171:572\u2013581. https:\/\/doi.org\/10.1176\/appi.ajp.2014.13060821","journal-title":"Am J Psychiatry"},{"key":"8045_CR49","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1532-5415.2009.02680.x","volume":"58","author":"T Okura","year":"2010","unstructured":"Okura T, Plassman BL, Steffens DC et al (2010) Prevalence of Neuropsychiatric Symptoms and Their Association with Functional limitations in older adults in the United States: the aging, demographics, and memory study. J Am Geriatr Soc 58:330\u2013337. https:\/\/doi.org\/10.1111\/j.1532-5415.2009.02680.x","journal-title":"J Am Geriatr Soc"},{"key":"8045_CR50","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s12603-020-1312-9","volume":"24","author":"A-N Yang","year":"2020","unstructured":"Yang A-N, Wang X-L, Rui H-R et al (2020) Neuropsychiatric symptoms and risk factors in mild cognitive impairment: a Cohort Investigation of Elderly patients. J Nutr Health Aging 24:237\u2013241. https:\/\/doi.org\/10.1007\/s12603-020-1312-9","journal-title":"J Nutr Health Aging"},{"key":"8045_CR51","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s00415-023-12131-0","volume":"271","author":"L Ronat","year":"2024","unstructured":"Ronat L, Hanganu A, Chylinski D et al (2024) Prediction of cognitive decline in healthy aging based on neuropsychiatric symptoms and PET-biomarkers of Alzheimer\u2019s disease. J Neurol 271:2067\u20132077. https:\/\/doi.org\/10.1007\/s00415-023-12131-0","journal-title":"J Neurol"},{"key":"8045_CR52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13195-020-00604-7","volume":"12","author":"TM Liew","year":"2020","unstructured":"Liew TM (2020) Neuropsychiatric symptoms in cognitively normal older persons, and the association with Alzheimer\u2019s and Non-alzheimer\u2019s dementia. Alzheimers Res Ther 12:35. https:\/\/doi.org\/10.1186\/s13195-020-00604-7","journal-title":"Alzheimers Res Ther"},{"key":"8045_CR53","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jagp.2019.03.023","volume":"28","author":"MH Burhanullah","year":"2020","unstructured":"Burhanullah MH, Tschanz JT, Peters ME et al (2020) Neuropsychiatric symptoms as risk factors for Cognitive decline in clinically normal older adults: the Cache County study. Am J Geriatr Psychiatry 28:64\u201371. https:\/\/doi.org\/10.1016\/j.jagp.2019.03.023","journal-title":"Am J Geriatr Psychiatry"},{"key":"8045_CR54","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3233\/JPD-160874","volume":"6","author":"Y-S Oh","year":"2016","unstructured":"Oh Y-S, Choi JH, Kwon D-Y (2016) Classification of scans without evidence of dopamine deficit (SWEDD) according to the olfactory function. J Park Dis 6:771\u2013778. https:\/\/doi.org\/10.3233\/JPD-160874","journal-title":"J Park Dis"},{"key":"8045_CR55","doi-asserted-by":"publisher","first-page":"103592","DOI":"10.1016\/j.nicl.2024.103592","volume":"42","author":"C Boccalini","year":"2024","unstructured":"Boccalini C, Nicastro N, Perani D, Garibotto V (2024) Distinctive clinical and imaging trajectories in SWEDD and Parkinson\u2019s disease patients. NeuroImage Clin 42:103592. https:\/\/doi.org\/10.1016\/j.nicl.2024.103592","journal-title":"NeuroImage Clin"},{"key":"8045_CR56","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/life11080804","volume":"11","author":"L Magistrelli","year":"2021","unstructured":"Magistrelli L, Contaldi E, Comi C (2021) The impact of SNCA variations and its product alpha-synuclein on Non-motor features of Parkinson\u2019s Disease. Life 11:804. https:\/\/doi.org\/10.3390\/life11080804","journal-title":"Life"},{"key":"8045_CR57","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.parkreldis.2019.10.002","volume":"73","author":"SG Ryman","year":"2020","unstructured":"Ryman SG, Poston KL (2020) MRI biomarkers of motor and non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat Disord 73:85\u201393. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.10.002","journal-title":"Parkinsonism Relat Disord"},{"key":"8045_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4018\/IJQSPR.290011","volume":"7","author":"AR Cingireddy","year":"2022","unstructured":"Cingireddy AR, Ghosh R, Melapu VK et al (2022) Classification of Parkinson\u2019s disease using motor and non-motor biomarkers through machine learning techniques. Int J Quant Struct-Prop Relatsh IJQSPR 7:1\u201321. https:\/\/doi.org\/10.4018\/IJQSPR.290011","journal-title":"Int J Quant Struct-Prop Relatsh IJQSPR"},{"key":"8045_CR59","doi-asserted-by":"crossref","unstructured":"Shu Z, Pang P, Wu X et al (2020) An Integrative Nomogram for Identifying Early-Stage Parkinson\u2019s Disease Using Non-motor Symptoms and White Matter-Based Radiomics Biomarkers From Whole-Brain MRI. Front Aging Neurosci 12","DOI":"10.3389\/fnagi.2020.548616"},{"key":"8045_CR60","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/jimaging8040097","volume":"8","author":"H Khachnaoui","year":"2022","unstructured":"Khachnaoui H, Khlifa N, Mabrouk R (2022) Machine learning for early Parkinson\u2019s Disease Identification within SWEDD Group using clinical and DaTSCAN SPECT Imaging features. J Imaging 8:97. https:\/\/doi.org\/10.3390\/jimaging8040097","journal-title":"J Imaging"},{"key":"8045_CR61","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1186\/s40064-016-3110-8","volume":"5","author":"M Kim","year":"2016","unstructured":"Kim M, Park H (2016) Structural connectivity profile of scans without evidence of dopaminergic deficit (SWEDD) patients compared to normal controls and Parkinson\u2019s disease patients. SpringerPlus 5:1421. https:\/\/doi.org\/10.1186\/s40064-016-3110-8","journal-title":"SpringerPlus"},{"key":"8045_CR62","doi-asserted-by":"publisher","unstructured":"Kim M, Park H (2016) Using Tractography to Distinguish SWEDD from Parkinson\u2019s Disease Patients Based on Connectivity. Park Dis 2016(e8704910). https:\/\/doi.org\/10.1155\/2016\/8704910","DOI":"10.1155\/2016\/8704910"},{"key":"8045_CR63","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1002\/mds.22323","volume":"23","author":"SS O\u2019Sullivan","year":"2008","unstructured":"O\u2019Sullivan SS, Burn DJ, Holton JL, Lees AJ (2008) Normal dopamine transporter single photon-emission CT scan in corticobasal degeneration. Mov Disord 23:2424\u20132426. https:\/\/doi.org\/10.1002\/mds.22323","journal-title":"Mov Disord"},{"key":"8045_CR64","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1007\/s00415-013-6886-2","volume":"260","author":"V Kaasinen","year":"2013","unstructured":"Kaasinen V, Gardberg M, R\u00f6ytt\u00e4 M et al (2013) Normal dopamine transporter SPECT in neuropathologically confirmed corticobasal degeneration. J Neurol 260:1410\u20131411. https:\/\/doi.org\/10.1007\/s00415-013-6886-2","journal-title":"J Neurol"},{"key":"8045_CR65","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1002\/mds.25671","volume":"28","author":"AE Lang","year":"2013","unstructured":"Lang AE, Eberly S, Goetz CG et al (2013) Movement Disorder Society Unified Parkinson Disease Rating Scale experiences in daily living: longitudinal changes and correlation with other assessments. Mov Disord 28:1980\u20131986. https:\/\/doi.org\/10.1002\/mds.25671","journal-title":"Mov Disord"},{"key":"8045_CR66","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.0000000000000424","volume":"82","author":"K Marek","year":"2014","unstructured":"Marek K, Seibyl J, Eberly S et al (2014) Longitudinal follow-up of SWEDD subjects in the PRECEPT study. Neurology 82:1791\u20131797. https:\/\/doi.org\/10.1212\/WNL.0000000000000424","journal-title":"Neurology"},{"key":"8045_CR67","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.parkreldis.2014.04.022","volume":"20","author":"J McKinley","year":"2014","unstructured":"McKinley J, O\u2019Connell M, Farrell M, Lynch T (2014) Normal dopamine transporter imaging does not exclude multiple system atrophy. Parkinsonism Relat Disord 20:933\u2013934. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.04.022","journal-title":"Parkinsonism Relat Disord"},{"key":"8045_CR68","doi-asserted-by":"publisher","unstructured":"Sasaki S (2024) Long-term follow-up study of SWEDD patients with mild parkinsonian signs. BMJ Neurol Open 6. https:\/\/doi.org\/10.1136\/bmjno-2023-000600","DOI":"10.1136\/bmjno-2023-000600"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08045-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-025-08045-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-025-08045-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T06:24:53Z","timestamp":1747376693000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-025-08045-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["8045"],"URL":"https:\/\/doi.org\/10.1007\/s10072-025-08045-6","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"7 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"PPMI is a large multicenter study and each site independently received ethics approval of the protocol. All subjects gave written informed consent in accordance with the Declaration of Helsinki. See Marek et al. (2011) and the online PPMI protocol for details of the PPMI study and image acquisition, respectively. Ethics committee approval and individual patient consents were received by the PPMI (https:\/\/www.ppmi-info.org\/study-design\/research-documents-and-sops). The present study was approved by the Comit\u00e9 d\u2019\u00e9thique de la recherche vieillissement-neuroimagerie CER VN 19-20-06.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval\u00a0and Informed consent statement"}},{"value":"The author declares that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}